Show simple item record

dc.contributor.authorBeggiato, Sarah
dc.contributor.authorZuccarini, Mariachiara
dc.contributor.authorCassano, Tommaso
dc.contributor.authorBorroto-Escuela, Dasiel Oscar
dc.contributor.authorDi Iorio, Patrizia
dc.contributor.authorSchwarcz, Robert
dc.contributor.authorFuxe, Kjell
dc.contributor.authorFerraro, Luca
dc.date.accessioned2021-05-05T17:55:20Z
dc.date.available2021-05-05T17:55:20Z
dc.date.issued2021-04-14
dc.identifier.urihttp://hdl.handle.net/10713/15585
dc.description.urihttps://doi.org/10.3389/fphar.2021.654426en_US
dc.description.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080066/en_US
dc.language.isoenen_US
dc.publisherFrontiers Media S.A.en_US
dc.relation.ispartofFrontiers in Pharmacologyen_US
dc.subjectadenosine A1 and A2A receptorsen_US
dc.subjectcognitionen_US
dc.subjectcombinatory therapyen_US
dc.subjectkynurenine pathwayen_US
dc.subjectreceptor heteromersen_US
dc.titleAdenosine and Kynurenic Acid Interactions: Possible Relevance for Schizophrenia Treatment?en_US
dc.typeArticleen_US
dc.identifier.doi10.3389/fphar.2021.654426
dc.identifier.pmid33935767
dc.source.volume12
dc.source.beginpage654426
dc.source.endpage
dc.source.countrySwitzerland


This item appears in the following Collection(s)

Show simple item record